金钱激励与同伴转介促进中国男男性行为者HIV自检二次分发:一项随机对照试验
这项三臂随机对照单盲试验于2019年10月21日至2020年9月14日在线纳入309名男男性行为者(MSM)作为索引参与者,评估金钱激励与同伴转介对HIV自检二次分发的促进作用。结果显示,接受金钱激励的SD-M组和接受金钱激励加同伴转介的SD-M-PR组在激励受检者及新受检者数量上均高于对照组,且未报告研究相关不良事件。作者结论认为金钱激励单独或联合同伴转介均可促进HIV自检二次分发。
要点
- 与对照组相比,SD-M组和SD-M-PR组索引参与者激励更多受检者及新受检者进行HIV自检。
- 金钱激励单独方案在受检者及新受检者数量上平均更具成本效果,尽管SD-M-PR组效应更大。
- 研究期间未报告研究相关不良事件。
核心结论
- 金钱激励单独使用以及金钱激励联合同伴转介均可促进MSM中HIV自检的二次分发。
- 金钱激励还可通过鼓励MSM二次分发中的首次检测来扩大HIV检测。
- 这种基于社交网络的数字化方法可扩展至其他公共卫生研究,尤其在COVID-19时代。
研究设计与样本
- 2019年10月21日至2020年9月14日开展在线三臂随机对照单盲试验,纳入309名索引参与者。
- 索引参与者随机分为标准二次分发对照组(n=102)、金钱激励二次分发SD-M组(n=103)和金钱激励加同伴转介SD-M-PR组(n=104)。
- 索引参与者和受检者订购试剂盒均需支付15美元可退还押金,两个干预组索引参与者每名唯一受检者上传核实检测结果后可获3美元固定激励。
- 主要结局为每组索引参与者激励的平均受检者数和平均新受检者数,采用零膨胀负二项回归分析,按意向性治疗分析。
- 从卫生提供者视角进行微观成本法经济评价,时间跨度3个月。
主要发现
- 索引参与者激励的平均唯一受检者数:对照组0.57±0.96,SD-M组0.98±1.38(均差MD=0.41),SD-M-PR组1.78±2.05(MD=1.21)。
- 索引参与者激励的平均新受检者数:对照组0.16±0.39,SD-M组0.41±0.73(MD=0.25),SD-M-PR组0.57±0.91(MD=0.41)。
- 对照组对比SD-M组激励唯一受检者的发生率比IRR=2.98(95%CI 1.82至4.89,P<0.001);对照组对比SD-M-PR组IRR=3.26(95%CI 2.29至4.63,P<0.001)。
- 对照组对比SD-M组激励新受检者的IRR=4.22(95%CI 1.93至9.23,P<0.001);对照组对比SD-M-PR组IRR=3.49(95%CI 1.92至6.37,P<0.001)。
- 受检者中新受检者比例:对照组28%,SD-M组42%,SD-M-PR组32%;共18名检测者(3名索引参与者与15名受检者)HIV阳性,受检者HIV阳性率三组间相似。
关键数值与推荐
- 共794名检测者总成本19,485.97美元,包括450名索引参与者和344名受检者检测者;平均每名检测者成本24.54美元,平均每名受检者检测者成本56.65美元。
- 与对照组相比,SD-M组每增加一名受检者检测者成本14.90美元,SD-M-PR组为16.61美元;每增加一名新受检者,SD-M组成本24.65美元,SD-M-PR组为49.07美元。
临床怎么用
- 作者结论认为金钱激励单独使用及金钱激励联合同伴转介均可促进MSM中HIV自检的二次分发。
- 作者结论认为金钱激励可通过鼓励首次检测扩大HIV检测。
- 作者认为这种基于社交网络的数字化方法可扩展至其他公共卫生研究,尤其在COVID-19时代。
局限性
- 数字化网络方法可能忽略缺乏互联网接入的个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Digital network-based methods may enhance peer distribution of HIV self-testing (HIVST) kits, but interventions that can optimize this approach are needed. We aimed to assess whether monetary incentives and peer referral could improve a secondary distribution program for HIVST among men who have sex with men (MSM) in China. METHODS AND FINDINGS: Between October 21, 2019 and September 14, 2020, a 3-arm randomized controlled, single-blinded trial was conducted online among 309 individuals (defined as index participants) who were assigned male at birth, aged 18 years or older, ever had male-to-male sex, willing to order HIVST kits online, and consented to take surveys online. We randomly assigned index participants into one of the 3 arms: (1) standard secondary distribution (control) group (n = 102); (2) secondary distribution with monetary incentives (SD-M) group (n = 103); and (3) secondary distribution with monetary incentives plus peer referral (SD-M-PR) group (n = 104). Index participants in 3 groups were encouraged to order HIVST kits online and distribute to members within their social networks. Members who received kits directly from index participants or through peer referral links from index MSM were defined as alters. Index participants in the 2 intervention groups could receive a fixed incentive ($3 USD) online for the verified test result uploaded to the digital platform by each unique alter. Index participants in the SD-M-PR group could additionally have a personalized peer referral link for alters to order kits online. Both index participants and alters needed to pay a refundable deposit ($15 USD) for ordering a kit. All index participants were assigned an online 3-month follow-up survey after ordering kits. The primary outcomes were the mean number of alters motivated by index participants in each arm and the mean number of newly tested alters motivated by index participants in each arm. These were assessed using zero-inflated negative binomial regression to determine the group differences in the mean number of alters and the mean number of newly tested alters motivated by index participants. Analyses were performed on an intention-to-treat basis. We also conducted an economic evaluation using microcosting from a health provider perspective with a 3-month time horizon. The mean number of unique tested alters motivated by index participants was 0.57 ± 0.96 (mean ± standard deviation [SD]) in the control group, compared with 0.98 ± 1.38 in the SD-M group (mean difference [MD] = 0.41),and 1.78 ± 2.05 in the SD-M-PR group (MD = 1.21). The mean number of newly tested alters motivated by index participants was 0.16 ± 0.39 (mean ± SD) in the control group, compared with 0.41 ± 0.73 in the SD-M group (MD = 0.25) and 0.57 ± 0.91 in the SD-M-PR group (MD = 0.41), respectively. Results indicated that index participants in intervention arms were more likely to motivate unique tested alters (control versus SD-M: incidence rate ratio [IRR = 2.98, 95% CI = 1.82 to 4.89, p-value < 0.001; control versus SD-M-PR: IRR = 3.26, 95% CI = 2.29 to 4.63, p-value < 0.001) and newly tested alters (control versus SD-M: IRR = 4.22, 95% CI = 1.93 to 9.23, p-value < 0.001; control versus SD-M-PR: IRR = 3.49, 95% CI = 1.92 to 6.37, p-value < 0.001) to conduct HIVST. The proportion of newly tested testers among alters was 28% in the control group, 42% in the SD-M group, and 32% in the SD-M-PR group. A total of 18 testers (3 index participants and 15 alters) tested as HIV positive, and the HIV reactive rates for alters were similar between the 3 groups. The total costs were $19,485.97 for 794 testers, including 450 index participants and 344 alter testers. Overall, the average cost per tester was $24.54, and the average cost per alter tester was $56.65. Monetary incentives alone (SD-M group) were more cost-effective than monetary incentives with peer referral (SD-M-PR group) on average in terms of alters tested and newly tested alters, despite SD-M-PR having larger effects. Compared to the control group, the cost for one more alter tester in the SD-M group was $14.90 and $16.61 in the SD-M-PR group. For newly tested alters, the cost of one more alter in the SD-M group was $24.65 and $49.07 in the SD-M-PR group. No study-related adverse events were reported during the study. Limitations include the digital network approach might neglect individuals who lack internet access. CONCLUSIONS: Monetary incentives alone and the combined intervention of monetary incentives and peer referral can promote the secondary distribution of HIVST among MSM. Monetary incentives can also expand HIV testing by encouraging first-time testing through secondary distribution by MSM. This social network-based digital approach can be expanded to other public health research, especially in the era of the Coronavirus Disease 2019 (COVID-19). TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR) ChiCTR1900025433.
引用
- Zhou Y, Lu Y, Ni Y, et al. Monetary incentives and peer referral in promoting secondary distribution of HIV self-testing among men who have sex with men in China: A randomized controlled trial. PLoS Med. 2022. PMID: 35157727. doi:10.1371/journal.pmed.1003928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。